Skip to main content
. 2019 Apr 11;10:1686. doi: 10.1038/s41467-019-09659-z

Fig. 8.

Fig. 8

STAG2 deficient cancer cells harbor increased sensitivity to cytotoxic chemotherapeutic agents and small molecule inhibitors of DNA double-strand break repair. a Summary of results from chemotherapeutic screen in four pairs of STAG2 isogenic human cells (H4 glioblastoma, 42MGBA glioblastoma, TC-106 Ewing sarcoma, and RPE hTERT shTP53). All four pairs showed similar sensitivities for all agents. b Survival plots of STAG2 isogenic H4 glioblastoma cells following treatment with etoposide (topoisomerase II inhibitor), rucaparib (PARP inhibitor), VX-970 (ATR inhibitor), and panobinostat (HDAC inhibitor). Each data point is the mean of 12 replicates from 3 independent experiments, and error bars show standard error of the mean. Source data are provided as a Source Data file